Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Shares Outstanding (Diluted Average): 2017-2021

Historic Shares Outstanding (Diluted Average) for BIO-TECHNE (TECH) over the last 5 years, with Jun 2021 value amounting to $40.5 million.

  • BIO-TECHNE's Shares Outstanding (Diluted Average) rose 2.36% to $41.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $41.2 million, marking a year-over-year increase of 2.36%. This contributed to the annual value of $40.5 million for FY2021, which is 2.75% up from last year.
  • As of FY2021, BIO-TECHNE's Shares Outstanding (Diluted Average) stood at $40.5 million, which was up 2.75% from $39.4 million recorded in FY2020.
  • Over the past 5 years, BIO-TECHNE's Shares Outstanding (Diluted Average) peaked at $40.5 million during FY2021, and registered a low of $37.5 million during FY2017.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $39.4 million (2020), whereas its average is $39.6 million.
  • Data for BIO-TECHNE's Shares Outstanding (Diluted Average) shows a peak YoY grew of 2.75% (in 2021) over the last 5 years.
  • BIO-TECHNE's Shares Outstanding (Diluted Average) (Yearly) stood at $37.5 million in 2017, then grew by 1.48% to $38.1 million in 2018, then grew by 2.20% to $38.9 million in 2019, then rose by 1.31% to $39.4 million in 2020, then climbed by 2.75% to $40.5 million in 2021.